Table 3 Toxicities observed in our patients during 30 days after initiation of gefitinib treatment
Toxicities | N = 18 | |
|---|---|---|
Number (%) | ||
Any | ≥ Grade 3 | |
Diarrhea | 9 (50) | 1 (5.6) |
Rash | 5 (28) | 0 (0) |
Anorexia | 4 (22) | 0 (0) |
Fatigue | 4 (22) | 0 (0) |
Nausea | 2 (11) | 0 (0) |
Dry skin | 2 (11) | 0 (0) |
Mucositis | 2 (11) | 0 (0) |
AST increase | 1 (5.6) | 1 (5.6) |
ALT increase | 1 (5.6) | 1 (5.6) |
Vomiting | 1 (5.6) | 0 (0) |
Pharyngitis | 1 (5.6) | 0 (0) |